D-0219-2017 Class I Terminated

Recalled by US Compounding Inc — Conway, AR

FDA drug recall D-0219-2017 was initiated by US Compounding Inc on Jul 25, 2016 and is designated Class I. Reason for recall: Microbial Contamination of Non-Sterile Products; microbial contamination with B. cepacia The recall status is terminated (terminated Apr 6, 2017). Affected quantity: 10,665 syringes.

Recall Details

Product Type
Drugs
Report Date
Dec 28, 2016
Initiation Date
Jul 25, 2016
Termination Date
Apr 6, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
10,665 syringes

Product Description

Docusate Oral 10 mg/mL Oral Syringe, packaged in a) 1 mL (62295-0601-01), b) 2 mL ( 62295-0601-02), and c) 5 mL syringes (62295-0601-05), US Compounding, Conway, AR

Reason for Recall

Microbial Contamination of Non-Sterile Products; microbial contamination with B. cepacia

Distribution Pattern

TX

Code Information

All Lots

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0219-2017
openFDA file date
Nov 3, 2026
Loaded by RegDataLab
Nov 4, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0219-2017. Report a data issue: hello@regdatalab.com.